Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 USD | +0.46% | +19.49% | +47.09% |
06-20 | Ocular Therapeutix Shares Rise After TD Cowen Upgrades Rating, Increases Price Target | MT |
06-20 | TD Cowen Upgrades Ocular Therapeutix to Buy From Hold, Adjusts Price Target to $11 From $7 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.09% | 1.02B | |
+55.19% | 815B | |
+47.26% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.40% | 247B | |
+3.64% | 229B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- OCUL Stock
- News Ocular Therapeutix, Inc.
- Ocular Therapeutix : Piper Sandler Adjusts Price Target on Ocular Therapeutix to $20 From $27, Maintains Overweight Rating